Know Cancer

or
forgot password

    • cancer clinical trials in houston, TX

    • Setup Variation in the Supraclavicular Lymph Nodes Treatment in Breast Cancer Patients
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Breast Cancer
    Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02
    Baylor University Medical Center - Houston
    Houston, Texas 77030-2399
    Breast Cancer, Fatigue, Sleep Disorders
    Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological Malignancies
    ARIAD Investigational Site #005
    Houston, Texas 70030
    Chronic Myelogenous Leukemia, Hematologic Malignancies
    Sexual Behavior in Head and Neck Cancer Patients
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Oropharyngeal Cancer, Head and Neck Cancer, Squamous Cell Carcinoma
    Prospective Observational Epidemiologic Study of Maraviroc's Safety
    Pfizer Investigational Site
    Houston, Texas 77030
    Human Immunodeficiency Virus
    Treatment of Macroglobulinemic Lymphoma With 2CdA, Cyclophosphamide and Rituximab
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Lymphoma
    A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma
    MD Anderson Cancer Center
    Houston, Texas 77030-4096
    Osteosarcoma, Malignant Fibrous Histiocytoma (MFH) of Bone
    A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Prostate Cancer
    Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS)
    MD Anderson Cancer Center
    Houston, Texas 77030-4096
    Ductal Carcinoma In Situ
    Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's -Like Leukemia/Lymphoma
    The University of Texas M. D. Anderson Cancer Center
    Houston, Texas 77030
    Burkitt's Lymphoma, Burkitt'S-like Lymphoma
    Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies
    MD Anderson Cancer Center/University of Texas Dept.ofMDAndersonCancerCtr(3)
    Houston, Texas 77030-4009
    Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma
    Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Leukemia, Acute Lymphoblastic Leukemia
    Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Malignant Gliomas
    Evaluation of Robot-Assisted Surgery in Gynecologic Oncology
    UT MD Anderson Cancer Center

    Trial Locations
    UT MD Anderson Cancer Center
    St. Luke's Episcopal Hospital
    Gynecologic Cancer
    INCB018424 in Patients With Advanced Hematologic Malignancies
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome, Chronic Myelogenous Leukemia
    Palliative Care and Symptom Management for the Pediatric Oncology Patient
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Pediatric Cancers
    Quantitative Analysis of Outcomes in Breast Reconstruction
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Breast Cancer
    Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
    Pfizer Investigational Site
    Houston, Texas 77030
    Kidney Neoplasms
    Cixutumumab and Temsirolimus in Treating Patients With Locally Advanced or Metastatic Cancer
    M D Anderson Cancer Center
    Houston, Texas 77030
    Malignant Neoplasm
    Literacy and Smoking Risk Communications
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Smoking
    S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer
    Veterans Affairs Medical Center - Houston

    Trial Locations
    Veterans Affairs Medical Center - Houston
    Baylor University Medical Center - Houston
    Ben Taub General Hospital
    St. Luke's Texas Cancer Institute at St. Luke's Episcopal Hospital
    Colorectal Cancer
    Inflammatory Cytokines in Symptom Production in Multiple Myeloma
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Multiple Myeloma
    Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
    M. D. Anderson Cancer Center at University of Texas

    Trial Locations
    M. D. Anderson Cancer Center at University of Texas
    Lyndon B. Johnson General Hospital
    Cervical Cancer
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Methodist Hospital

    Trial Locations
    Methodist Hospital
    Veterans Administration Medical Center
    Saint Luke's Episcopal Hospital
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme
    University of Texas M.D. Anderson Cancer Center
    Houston, Texas 77030
    Glioblastoma Multiforme
    Continuous Glucose Monitoring in Critically Ill
    University of Texas Health Science Center at Houston

    Trial Locations
    University of Texas Health Science Center at Houston
    UT MD Anderson Cancer Center
    Diabetes
    Study of the T-cells or EBV Specific CTLs for Advanced B-Cell Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia
    The Methodist Hospital
    Houston, Texas 77030
    Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia
    CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene
    Texas Children's Hospital

    Trial Locations
    Texas Children's Hospital
    The Methodist Hospital
    Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma
    Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)
    Texas Children's Hospital

    Trial Locations
    Texas Children's Hospital
    The Methodist Hospital
    Adenovirus Infection, EBV Infection
    Pre-Surgical Sutent in Renal Cell Carcinoma (RCC)
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Renal Cell Carcinoma
    Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Baylor College of Medicine
    Houston, Texas 77030
    Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
    M.D. Anderson Cancer Center at University of Texas

    Trial Locations
    M.D. Anderson Cancer Center at University of Texas
    The Methodist Hospital Neurological Institute
    Brain and Central Nervous System Tumors
    A Long-Term Study of the Effects of Orally Administered SAR302503 in Patients With Myelofibrosis
    MD Anderson Cancer Center
    Houston, Texas 77030-4096
    Myelofibrosis
    Laparoscopic-Assisted Resection or Open Resection in Treating Patients With Stage IIA, Stage IIIA, or Stage IIIB Rectal Cancer
    M. D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030-4009
    Colorectal Cancer
    BIBW 2992 (Afatinib) With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant Glioma
    1200.36.0010 Boehringer Ingelheim Investigational Site
    Houston, Texas
    Glioma
    A Safety And Efficacy Study Of The Combination Of Oral PF-00299804 And Intravenous CP-751,871 Given Every 3 Weeks
    Pfizer Investigational Site
    Houston, Texas 77030
    Carcinoma, Non-Small Cell, Neoplasm Metastasis
    A Study To Test The Impact Of PF- 00299804 On How The Body Handles Dextromethorphan In Cancer Patients
    Pfizer Investigational Site
    Houston, Texas 77030
    Advanced Malignant Solid Tumors
    Multiple Ascending Dose (MDX1105-01)
    Oncology Consultants, PA

    Trial Locations
    Oncology Consultants, PA
    The University of Texas
    Cancer, Multiple Indications
    Longitudinal Assessment of Arthralgia and Related Symptoms in Breast Cancer
    UT MD . Anderson Cancer Center
    Houston, Texas 77030
    Breast Cancer
    MLN8237 in Young Patients With Relapsed or Refractory Solid Tumors or Acute Lymphoblastic Leukemia
    Baylor University Medical Center - Houston
    Houston, Texas 77030-2399
    Leukemia, Neuroblastoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Phase II Study of Oral Panobinostat in Adult Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma
    MD Anderson Cancer Center/University of Texas Dept.ofMDAndersonCancerCtr(3)

    Trial Locations
    MD Anderson Cancer Center/University of Texas Dept.ofMDAndersonCancerCtr(3)
    The Baylor College of Medicine/The Methodist Hospital Cell & Gene Therapy Clinic
    Classical Hodgkin's Lymphoma (i.e. Nodular Sclerosing, Mixed-cellularity, Lymphocyte-rich, Lymphocyte-depleted)